Literature DB >> 7102709

Acyclovir in herpes keratitis.

L M Collum, P Logan, I B Hillary, T Ravenscroft.   

Abstract

Herpes simplex keratitis accounts for 50 percent of patients presenting at our corneal clinic. Studies of the use of acyclovir in dendritic and geographic ulceration and disciform keratitis are presented. In a double-blind study of acyclovir and idoxuridine in 60 patients with dendritic keratitis, acyclovir was shown to be superior and produced no serious side effects. Patients with geographic ulcers have been treated on an open basis with acyclovir and the drug was found to be effective. A combination of acyclovir and dilute steroid drops appeared to be as effective as currently available treatments in the management of disciform keratitis. Double-blind studies are now in progress to evaluate acyclovir in geographic and disciform keratitis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7102709     DOI: 10.1016/0002-9343(82)90108-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  7 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  The treatment of herpes simplex virus epithelial keratitis.

Authors:  K R Wilhelmus
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 3.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

4.  Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration.

Authors:  L M Collum; P Logan; D McAuliffe-Curtin; S O Hung; A Patterson; P J Rees
Journal:  Br J Ophthalmol       Date:  1985-11       Impact factor: 4.638

5.  Acyclovir treatment in stromal herpetic keratitis.

Authors:  J A Oosterhuis; R van Ganswijk; J Versteeg
Journal:  Doc Ophthalmol       Date:  1983-12-15       Impact factor: 2.379

Review 6.  Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy.

Authors:  D M Richards; A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-11       Impact factor: 9.546

Review 7.  Adoption of Innovation in Herpes Simplex Virus Keratitis.

Authors:  James Chodosh; Lawson Ung
Journal:  Cornea       Date:  2020-11       Impact factor: 3.152

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.